JPMorgan Upgrades Adient (ADNT) to Overweight
Tweet
Share
E-mailGet Alerts ADNT Hot Sheet
Price: $17.46 -1.24%
Rating Summary:
11 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
11 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
JPMorgan analyst Rajat Gupta upgraded Adient (NYSE: ADNT) from Neutral to Overweight with a price target of $25.00 (from $28.00).
For an analyst ratings summary and ratings history on Adient click here. For more ratings news on Adient click here.
Shares of Adient closed at $18.76 yesterday.
You May Also Be Interested In
- BofA Securities Upgrades Candel Therapeutics Inc. (CADL) to Buy
- Desjardins Resumes Apotex Health Corp (APTX:CN) at Buy
- Teradata (TDC) PT Lowered to $32 at UBS on Cautious Q3 View
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
